Immuto Scientific is a biotechnology company transforming the discovery of next generation therapeutics. Protein structural analysis is central to drug development, yet existing methods are slow, sample intensive, and often lack the resolution needed to guide rational design. Immuto’s proprietary platform delivers native state, residue level insights into protein structure, binding, and interactions with unprecedented accuracy and speed.

 Our suite of technologies enables researchers to rapidly de-risk candidates, optimize leads, and advance programs with greater confidence. With high throughput workflows that generate AI ready datasets, Immuto also bridges experimental biology and computational modeling, empowering AI driven teams to refine predictions and accelerate iteration. By providing actionable structural insights in weeks rather than months, we help partners unlock rational design, reduce risk, and bring transformative therapeutics to patients faster.